"The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections.
Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) cau"...
- Patient Information:
Details with Side Effects
Patients with scabies should be advised that itching, mild burning and/or stinging may occur after application of ELIMITE® (permethrin) 5% Cream. In clinical trials, approximately 75% of patients treated with ELIMITE® (permethrin) 5% Cream who continued to manifest pruritus at 2 weeks had cessation by 4 weeks. If irritation persists, they should consult their physician. ELIMITE® (permethrin) 5% Cream may be very mildly irritating to the eyes. Patients should be advised to avoid contact with eyes during application and to flush with water immediately if ELIMITE® (permethrin) 5% Cream gets in the eyes.
Last reviewed on RxList: 4/30/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Elimite Information
Elimite - User Reviews
Elimite User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.